The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
43
November 23, 2005Nov 23, 2005
Free
DOWNLOAD THE PDF

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account